<DOC>
	<DOCNO>NCT00277823</DOCNO>
	<brief_summary>The purpose study compare antidepressant efficacy , safety , tolerability DVS-SR subject receive daily dos 50 mg 100 mg DVS-SR versus subject receive placebo .</brief_summary>
	<brief_title>Study Evaluating Desvenlafaxine Sustained-Release ( DVS-SR ) Adult Outpatients With Major Depressive Disorder</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<mesh_term>Desvenlafaxine Succinate</mesh_term>
	<criteria>Clinical diagnosis major depressive disorder Must able swallow tablet Must least 18 year age . Clinical diagnosis psychiatric disorder Significant risk suicide Unstable medical condition .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2007</verification_date>
	<keyword>Depression</keyword>
	<keyword>Adult</keyword>
	<keyword>Outpatients</keyword>
</DOC>